Skip to main content
Erschienen in: Neuroradiology 8/2013

01.08.2013 | Diagnostic Neuroradiology

Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies

verfasst von: Shinichiro Kitao, Eiji Matsusue, Shinya Fujii, Fuminori Miyoshi, Toshio Kaminou, Shinsuke Kato, Hisao Ito, Toshihide Ogawa

Erschienen in: Neuroradiology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Direct correlation between neuropathological findings and postmortem neuromelanin MR imaging (NmMRI) was performed in the substantia nigra pars compacta (SNc) to clarify the pathological background of the signal changes in normal, Parkinson’s disease (PD), and dementia with Lewy bodies (DLB) cases.

Methods

NmMRI of 10 % formalin-fixed autopsied midbrains was performed in three cases (normal control, DLB, and PD) with a 3T imaging system, using a 3D gradient echo T1-weighted sequence with a magnetization transfer contrast pulse. Neuropathological examinations of the midbrains were performed, and the density of neuromelanin-positive neurons (number per square millimeter) was determined. The extent of iron deposition in the midbrain was also evaluated using ferritin immunohistochemistry. Furthermore, we directly correlated the contrast signal ratio in the SNc and the density of neuromelanin-containing neurons.

Results

Diffuse hyperintense areas in the SNc reflected well-preserved neuromelanin-containing neurons in the normal control case, whereas an iso-intense area in the SNc showed severe loss of neuromelanin-containing neurons in the DLB and PD cases. Increased signal intensity in the SNc was apparently not influenced by iron deposition. Furthermore, a significant positive correlation between signal intensity and the density of neuromelanin-containing neurons was seen in the SNc.

Conclusion

Based on the direct correlation between postportem NmMRI and neuropathological findings, signal intensity in the SNc is closely related to the quantity of neuromelanin-containing neurons but is not influenced by iron deposition.
Literatur
1.
Zurück zum Zitat Marsden D (1965) Brain pigment and its relation to brain catecholamines. Lancet 10:475–76CrossRef Marsden D (1965) Brain pigment and its relation to brain catecholamines. Lancet 10:475–76CrossRef
2.
Zurück zum Zitat Graham DG (1979) On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359–62PubMed Graham DG (1979) On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359–62PubMed
3.
Zurück zum Zitat Bazelon M, Fenichel GM, Randall J (1967) Studies on neuromelanin: I. A melanin system in the human adult brainstem. Neurology 17:512–18PubMedCrossRef Bazelon M, Fenichel GM, Randall J (1967) Studies on neuromelanin: I. A melanin system in the human adult brainstem. Neurology 17:512–18PubMedCrossRef
4.
Zurück zum Zitat Enochs WS, Hyslop WB, Bennett HF et al (1997) Sources of the increased longitudinal relaxation rates observed in melanotic melanoma: an in vitro study of synthetic melanins. Invest Radiol 24:794–804CrossRef Enochs WS, Hyslop WB, Bennett HF et al (1997) Sources of the increased longitudinal relaxation rates observed in melanotic melanoma: an in vitro study of synthetic melanins. Invest Radiol 24:794–804CrossRef
5.
Zurück zum Zitat Enochs WS, Petherick P, Bogdanova A et al (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–23PubMed Enochs WS, Petherick P, Bogdanova A et al (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–23PubMed
6.
Zurück zum Zitat Sasaki M, Shibata E, Tohyama K et al (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport 17:1215–8PubMedCrossRef Sasaki M, Shibata E, Tohyama K et al (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport 17:1215–8PubMedCrossRef
7.
Zurück zum Zitat Nakane T, Nihashi T, Kawai H et al (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7:205–10PubMedCrossRef Nakane T, Nihashi T, Kawai H et al (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7:205–10PubMedCrossRef
8.
Zurück zum Zitat McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47:1113–24PubMedCrossRef McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47:1113–24PubMedCrossRef
9.
Zurück zum Zitat McKeith IG, Dickson DW, Lowe J et al (2005) Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863–72PubMedCrossRef McKeith IG, Dickson DW, Lowe J et al (2005) Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863–72PubMedCrossRef
10.
Zurück zum Zitat Schwarz ST, Rittman T et al (2011) T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson’s disease. Movement Disorders 29:1633–38CrossRef Schwarz ST, Rittman T et al (2011) T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson’s disease. Movement Disorders 29:1633–38CrossRef
11.
Zurück zum Zitat Hallgren B, Sourander P (1958) The effect of age of the non/hemin iron in the human brain. J Neurochem 3:41–51PubMedCrossRef Hallgren B, Sourander P (1958) The effect of age of the non/hemin iron in the human brain. J Neurochem 3:41–51PubMedCrossRef
12.
Zurück zum Zitat Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with Parkinson disease, and patients with multiple system atrophy: relation of iron content. Radiology 211:489–95PubMed Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with Parkinson disease, and patients with multiple system atrophy: relation of iron content. Radiology 211:489–95PubMed
13.
Zurück zum Zitat Kinoshita T, Ogawa T, Yoshida Y et al (2005) Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 47:647–51PubMedCrossRef Kinoshita T, Ogawa T, Yoshida Y et al (2005) Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 47:647–51PubMedCrossRef
14.
Zurück zum Zitat Castillo M, Scatliff JH, Kwock L et al (1996) Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 16:241–50PubMed Castillo M, Scatliff JH, Kwock L et al (1996) Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 16:241–50PubMed
15.
Zurück zum Zitat van den Hauwe L, Parizel PM, Martin JJ et al (1995) Postmortem MRI of the brain with neuropathological correlation. Neuroradiology 37:343–9PubMedCrossRef van den Hauwe L, Parizel PM, Martin JJ et al (1995) Postmortem MRI of the brain with neuropathological correlation. Neuroradiology 37:343–9PubMedCrossRef
16.
Zurück zum Zitat Tovi M, Ericsson A (1992) Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol 33:400–4PubMed Tovi M, Ericsson A (1992) Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol 33:400–4PubMed
17.
Zurück zum Zitat Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 18:1093–6PubMedCrossRef Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 18:1093–6PubMedCrossRef
18.
Zurück zum Zitat Kashihara K, Shinya T, Higaki F (2011) Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med 50:1683–7PubMedCrossRef Kashihara K, Shinya T, Higaki F (2011) Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med 50:1683–7PubMedCrossRef
Metadaten
Titel
Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies
verfasst von
Shinichiro Kitao
Eiji Matsusue
Shinya Fujii
Fuminori Miyoshi
Toshio Kaminou
Shinsuke Kato
Hisao Ito
Toshihide Ogawa
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 8/2013
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-013-1199-9

Weitere Artikel der Ausgabe 8/2013

Neuroradiology 8/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.